A multi-center, randomized, double-blind, parallel-group, multiple dose, adaptive study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of TTP399 in adult patients with type 1 diabetes mellitus.
Clinical Trial Grant
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
vTv Therapeutics LLC
Start Date
June 29, 2018
End Date
May 19, 2020
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
vTv Therapeutics LLC
Start Date
June 29, 2018
End Date
May 19, 2020